Abstract
Dementia is a clinical syndrome that is characterized by impairment of cognitive and functional abilities (daily life activities) as well as by neuropsychiatric symptoms. Cognitive impairment can include impairment of memory, visuospatial functions, language, and executive functions. Many neurodegenerative diseases turn over to dementia, Alzheimer´s Disease being the most frequent of them. Alzheimer´s Disease (AD) affect a large population worldwide.
In the last decade, various medications have been used for the treatment of cognitive symptoms in AD. Many of them have few scientific evidence of their effectiveness. The aim of this paper is to review and update the current status of the pharmacological treatment of cognitive symptoms in Alzheimer´s Disease.
Keywords: Alzheimer's disease, cognitive symptoms, dementia, pharmacological treatment.
Current Psychopharmacology
Title:Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease
Volume: 3
Author(s): Patricio Perez Leguizamon, Carol Dillon, Diego M. Castro, Leandro Lon, Veronica Guelar and Fernando E. Taragano
Affiliation:
Keywords: Alzheimer's disease, cognitive symptoms, dementia, pharmacological treatment.
Abstract: Dementia is a clinical syndrome that is characterized by impairment of cognitive and functional abilities (daily life activities) as well as by neuropsychiatric symptoms. Cognitive impairment can include impairment of memory, visuospatial functions, language, and executive functions. Many neurodegenerative diseases turn over to dementia, Alzheimer´s Disease being the most frequent of them. Alzheimer´s Disease (AD) affect a large population worldwide.
In the last decade, various medications have been used for the treatment of cognitive symptoms in AD. Many of them have few scientific evidence of their effectiveness. The aim of this paper is to review and update the current status of the pharmacological treatment of cognitive symptoms in Alzheimer´s Disease.
Export Options
About this article
Cite this article as:
Leguizamon Perez Patricio, Dillon Carol, Castro M. Diego, Lon Leandro, Guelar Veronica and Taragano E. Fernando, Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease, Current Psychopharmacology 2014; 3 (1) . https://dx.doi.org/10.2174/2211556003666140717184049
DOI https://dx.doi.org/10.2174/2211556003666140717184049 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations
and Management in COVID-19 Pandemic
CNS & Neurological Disorders - Drug Targets Familial Alzheimers Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-β Protein Precursor Generated by β-Secretase Cleavage
Current Alzheimer Research Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Current Medicinal Chemistry Secondary Prevention of Ischemic Stroke
Current Drug Targets Genetic Variability of Matrix Metalloproteinase Genes in Cardiovascular Disease
Current Topics in Medicinal Chemistry Definition of Genes and Paths Involved in Alzheimers Disease: Using Gene Expression Profiles and Chemical Genetics at the Mouse Brain Level
Current Genomics Editorial (Thematic Issue:Drug-eluting Stents and Concomitant Treatment)
Cardiovascular & Hematological Disorders-Drug Targets Assessment of the Aggregation Propensity of the β -amyloid Peptide During the Synthesis and when Free in Solution
Protein & Peptide Letters Attitudinal & Knowledge Barriers Towards Effective Pain Assessment & Management in Dementia: A Narrative Synthesis
Current Alzheimer Research Impacts of Hyper-Homocysteinemia and White Matter Hyper-Intensity in Alzheimers Disease Patients with Normal Creatinine: An MRI-Based Study with Longitudinal Follow-up
Current Alzheimer Research Ameliorative Effect of Trans-Sinapic Acid and its Protective Role in Cerebral Hypoxia in Aluminium Chloride Induced Dementia of Alzheimer's Type
CNS & Neurological Disorders - Drug Targets Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer’s Disease
Current Neurovascular Research Editorial [ Medicines Da Vinci Code: Deciphering the Intricate Origins of Clinical Neurovascular Pathology K. Maiese ]
Current Neurovascular Research Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
Current Topics in Medicinal Chemistry The Use of Chronobiotics in the Resynchronization of the Sleep/Wake Cycle. Therapeutical Application in the Early Phases of Alzheimer's Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Pleiotropic Effects of Omega-3 Fatty Acids
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Mathematical Modelling and Feature Extraction for Probing Crucial Changes Associated with Alzheimers Disease
Current Medical Imaging Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair
Current Pharmaceutical Design Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Current Neuropharmacology Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation: Repurposing Via Neuroinformatics Approach
Current Pharmaceutical Design